Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-19T05:03:06.712Z Has data issue: false hasContentIssue false

What is a run-in phase?

Published online by Cambridge University Press:  11 April 2011

Andrea Cipriani*
Affiliation:
Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona (Italy)
John R. Geddes
Affiliation:
Department of Psychiatry, University of Oxford, Oxford (United Kingdom)
*
Address for correspondence: Dr. A. Cipriani, Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Piazzale L.A. Scuro 10, 37134 Verona (Italy). Fax: +39-045-8027498 Email: [email protected]

Abstract

Run-in periods are frequently used when designing a clinical trial. In this paper we analysed the implications of runin periods for interpreting the results of clinical trials and applying these results in clinical practice. Study reports should indicate in details how run-in periods were carried out.

Type
ABC of Methodology
Copyright
Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Accordini, S. (2007). An introduction to sample size calculations in clinical trials. Epidemiologia Psichiatria Sociale 16, 299301.CrossRefGoogle ScholarPubMed
Cipriani, A. & Geddes, J.R. (2009). What is a randomised controlled trial? Epidemiologia e Psichiatria Sociale 18, 191194.CrossRefGoogle ScholarPubMed
Cipriani, A., Purgato, M. & Barbui, C. (2009). Why internal and external validity of experimental studies are relevant for clinical practice? Epidemiologia e Psichiatria Sociale 18:101103.CrossRefGoogle ScholarPubMed
DeBrota, D.J., Demitrack, M.A., Landin, R., Kobak, K.A., Greist, J.H., & Potter, W.Z. (1999). A Comparison Between Interactive Voice Response System-Administered HAM-D and Clinician-Administered HAM-D in Patients with Major Depressive Episode. National Institute of Mental Health. In 39th Annual Meeting, New Clinical Drug Evaluation Unit, Boca Raton, FL.Google Scholar
Pablos-Méndez, A., Barr, R.G. & Shea, S. (1998). Run-in periods in randomized trials implications for the application of results in clinical practice. Journal of American Medical Association 279, 222225.CrossRefGoogle ScholarPubMed
Quitkin, F.M., McGrath, P.J., Stewart, J.W., Ocepek, W.K., Taylor, B.P. & Nunes, E. (1998). Placebo run-in period in studies of depressive disorders. Clinical, heuristic and research implications. British Journal of Psychiatry 173, 242248.CrossRefGoogle ScholarPubMed